Neurogene (NGNE) - Total pendapatan perusahaan
The operating revenue dynamics for Neurogene Inc. (NGNE) on the GURU.Markets chart demonstrate the current level of 0.00. This metric remains independent of market cycles, as the development of gene therapy is tied to FDA milestones. International tensions complicate the logistics of biomaterials and the execution of tests. The stability of the Rett syndrome patient base ensures the resilience of the Neurogene Inc. R&D ecosystem.
Rincian metrik komprehensif lan analitis Neurogene Therapeutics (NGNE)
- kuotasi saiki lan rata-rata prakiraan nilai:
- indikator kapitalisasi pasar:
- indikator nilai buku ekuitas:
- data liabilitas lan likuiditas perusahaan:
Rasio Kabeh Utang marang Dana Pribadi Neurogene Inc.|NGNE - Utang jangka dawa marang modal|Koefisien utang jangka cendhak marang modal Neurogene Therapeutics|NGNE - Utang perusahaan|Rasio utang marang nilai buku Neurogene Inc|NGNE - Utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan Neurogene|Koefisien jangkoan perantara neurogene.com
- rincian asil keuangan lan kelipatan valuasi:
NGNE - Bathi resik perusahaan|Prakiraan bathi resik Neurogene Inc.|NGNE - Pangali P/E|Pangali forward rega marang bathi Neurogene Inc|NGNE - Rasio rega marang bathi tumrap wutah|Nilai perusahaan marang bathi operasional sadurunge panyusutan Neurogene Inc|NGNE - Bathi operasional EBITDA|Bathi resik saben siji saham sajrone rolas wulan pungkasan Neurogene|NGNE - Bathi saben saham sajrone rolas wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone 12 wulan pungkasan neurogene.com|NGNE - Wutah bathi ing taun lumaku|Prakiraan wutah bathi resik saben saham ing taun ngarep Neurogene Inc.
- statistik dodolan lan pendapatan perusahaan:
Analisis komprehensif perusahaan:Neurogene Inc. NGNE
Assessing the investment reliability of equity assets begins with an analysis of cash flow stability. This indicator captures daily product sales revenue, measuring the speed of technology commercialization within the fundamental value. For Neurogene Inc. (NGNE), this metric reflects the market success of gene therapies for rare pathologies, including results for the NGN-401 drug. This price action confirms the effectiveness of the gene delivery platform. By examining the company's sales chronology, an investor can objectively assess the business growth rate.
Pesaing wigati
Volume dodolan perusahaan BIIB (Biogen)|Pendapatan perusahaan Neurocrine Biosciences, Inc. (NBIX)|Pendapatan perusahaan RGC (Regencell Bioscience Ltd)|Axsome Therapeutics, Inc. - Dodolan perusahaan|ACAD (ACADIA Pharmaceuticals Inc) - Pendapatan tahunan perusahaan|Xenon Corp - Pendapatan lan volume dodolan|Pendapatan dodolan perusahaan VKTX (Viking Therapeutics)|Supernus Pharmaceuticals (SUPN) - Pendapatan perusahaan|Pendapatan tahunan perusahaan CPRX (Catalyst Pharmaceuticals, Inc.)|Pendapatan perusahaan Denali Therapeutics Inc|Total pendapatan perusahaan Harmony Corp HRMY|Pendapatan lan volume dodolan BHVN|Dodolan perusahaan Amylyx Pharmaceuticals AMLX|Pendapatan lan volume dodolan TRVI (Trevi Corp)|Pendapatan reged perusahaan Praxis Precision Medicines, Inc. (PRAX)|Anavex Life Sciences Corp - Pendapatan lan volume dodolan|CeriBell Corp (CBLL) - Dodolan perusahaan|Prothena Corp (PRTA) - Pendapatan perusahaan|Total pendapatan perusahaan Alector Inc. (ALEC)|Dodolan perusahaan ANNX|omeros.com (OMER) - Pendapatan reged perusahaan|Pendapatan perusahaan AC Immune Corp (ACIU)|Total dodolan perusahaan VYGR|Pendapatan lan volume dodolan NMRA (neumoratx.com)|SCLX - Dodolan perusahaan|tevogen.com - Pendapatan lan volume dodolan|Total volume dodolan perusahaan Alpha Cognition Inc. (ACOG)|CGTX: Pendapatan lan volume dodolan|IKT - Pendapatan reged perusahaan|Dodolan perusahaan SAVA|Dodolan perusahaan Assertio (ASRT)|Dodolan perusahaan COYA (Coya)|Pendapatan perusahaan VTGN (VistaGen Therapeutics Inc)|Pendapatan perusahaan Ovid Therapeutics OVID|Pendapatan lan volume dodolan Acumen Pharma ABOS|CervoMed, Inc. - Pendapatan lan volume dodolan|Pendapatan dodolan perusahaan ATHE (alteritytherapeutics.com)|CLNN (Clene Nanomedicine) - Dodolan perusahaan|Total pendapatan perusahaan PepGen Corp (PEPG)|Pendapatan perusahaan Jupiter Neurosciences Inc|Total pendapatan perusahaan Relmada Therapeutics RLMD|Pendapatan perusahaan Annovis Bio (ANVS)|GRCE - Total pendapatan perusahaan|Pendapatan lan volume dodolan AIFF (Firefly Neuroscience, Inc)|Klotho Neurosciences Inc (KLTO) - Total pendapatan perusahaan|NeuroSense Therapeutics, Ltd. - Pendapatan lan volume dodolan|RVPH - Pendapatan lan volume dodolan|MetaVia Inc (MTVA) - Pendapatan perusahaan|NRXS - Pendapatan reged perusahaan|Pendapatan perusahaan heliusmedical.com|PASG - Total volume dodolan perusahaan|Pendapatan perusahaan Neuphoria (NEUP)|Pendapatan reged perusahaan Minerva|Pendapatan lan volume dodolan ATHA (Athira Pharma Corp)|Pendapatan dodolan perusahaan ADXN|Alzamend - Pendapatan lan volume dodolan|Cyclerion Therapeutics, Inc. (CYCN) - Dodolan perusahaan|protagenic.com (PTIX) - Pendapatan perusahaan|KTTA: Total dodolan perusahaan|CRGT (cortigent.com) - Pendapatan lan volume dodolan|ATXI (Avenue Therapeutics) - Total dodolan perusahaan|Pendapatan lan volume dodolan BCLI|Total dodolan perusahaan CARA|Pendapatan perusahaan chromocell.com CHRO|Pendapatan lan volume dodolan Eliem Therapeutics ELYM|ITCI: Dodolan perusahaan|LBPH: Pendapatan perusahaan|MRNS (Marinus Pharmaceuticals, Inc.) - Dodolan perusahaan|NKGen - Pendapatan dodolan perusahaan|Pendapatan perusahaan NeuroBo Pharmaceuticals, Inc.|Pendapatan lan volume dodolan Sage Therapeutics Inc|Pendapatan lan volume dodolan SNPX|TRVN - Total pendapatan perusahaan|Pendapatan perusahaan vigilneuro.com VIGL|Pendapatan reged perusahaan Anew Medical (WENA)|cerevel.com - Pendapatan lan volume dodolan
